Marie Ehrlichová - Concepedia

Author

Marie Ehrlichová

Also Known As

Ehrlichova, M., Ehrlichova, Marie, M Ehrlichova, M. Ehrlichova, M. Ehrlichová, MARIE EHRLICHOVA, Marie Ehrlichova, Marie Ehrlichová

Publications

830

Citations

H-Index

Concepts

All Affiliations

National Institute of Public Health Charles University Czech Academy of Sciences Czech Academy of Sciences, Institute of Molecular Genetics AeskuLab (Czechia)

About

Marie Ehrlichová is an author at National Institute of Public Health specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	405
2	Cell Biology	7	7	254
3	Biochemistry	4	4	127
4	Natural Sciences	3	3	97
5	Cellular Physiology	1	1	18

Marie Ehrlichová

Publications

812

Citations

H-Index

Page 1

	Year	Citations
The Expression Profile of Atp-Binding Cassette Transporter Genes in Breast Carcinoma Viktor Hlaváč, Veronika Brynychová, Radka Václavíková, Pharmacogenomics	2013	142
Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters Vlasta Němcová‐Fürstová, Dana Kopperová, Kamila Balušíková, Toxicology and Applied Pharmacology Tumor BiologyBreast OncologyAbc TransportersMedicinePaclitaxel Resistance	2016	112
Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma Katerina Elsnerová, Beatrice Mohelníková-Duchoňová, Ela Cerovská, Oncology Reports	2016	72
Association of superoxide dismutases and NAD(P)H quinone oxidoreductases with prognosis of patients with breast carcinomas Miluse Hubackova, Radka Václavíková, Marie Ehrlichová, International Journal of Cancer	2011	60
The effect of flavonoid derivatives on doxorubicin transport and metabolism Radka Václavíková, Eliška Kondrová, Marie Ehrlichová, Bioorganic & Medicinal Chemistry Medicinal ChemistryPolyphenolicsBiochemistryMedicineNatural Sciences	2007	46
Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells Marie Ehrlichová, Radka Václavíková, Iwao Ojima, Naunyn-Schmiedeberg s Archives of Pharmacology Breast OncologyOncologyPolymer-drug ConjugateMedicineBreast Cancer	2005	42
The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients Viktor Hlaváč, Veronika Brynychová, Radka Václavíková, Medicine Breast OncologyPathologyCytochromes P450Cancer BiologyTumor Biology	2014	33
The association of taxane resistance genes with the clinical course of ovarian carcinoma Marie Ehrlichová, Beatrice Mohelníková-Duchoňová, Jiří Hrdý, Genomics Taxane Resistance GenesClinical CourseEndocrine-related CancerOncogenic AgentMedicine	2013	31
Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells. Marie Ehrlichová, Michal Koc, Jaroslav Truksa, PubMed	2006	31
Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport? Radka Václavíková, Ahcène Boumendjel, Marie Ehrlichová, Bioorganic & Medicinal Chemistry Breast OncologyDrug TargetingBiochemistryMedicinePaclitaxel Transport	2006	29

Page 1